Novartis AG (NVSEF)
102.14
+1.52
(+1.51%)
USD |
OTCM |
May 17, 16:00
Novartis Price to Book Value: 5.253 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 17, 2024 | 5.253 |
May 16, 2024 | 5.175 |
May 15, 2024 | 5.175 |
May 14, 2024 | 5.246 |
May 13, 2024 | 5.246 |
May 10, 2024 | 5.245 |
May 09, 2024 | 4.972 |
May 08, 2024 | 5.119 |
May 07, 2024 | 4.951 |
May 06, 2024 | 4.898 |
May 03, 2024 | 4.872 |
May 02, 2024 | 4.988 |
May 01, 2024 | 4.988 |
April 30, 2024 | 4.988 |
April 29, 2024 | 4.937 |
April 26, 2024 | 4.937 |
April 25, 2024 | 4.937 |
April 24, 2024 | 4.937 |
April 23, 2024 | 4.937 |
April 22, 2024 | 4.891 |
April 19, 2024 | 4.641 |
April 18, 2024 | 4.641 |
April 17, 2024 | 4.816 |
April 16, 2024 | 4.816 |
April 15, 2024 | 4.816 |
Date | Value |
---|---|
April 12, 2024 | 4.816 |
April 11, 2024 | 4.816 |
April 10, 2024 | 4.839 |
April 09, 2024 | 4.922 |
April 08, 2024 | 4.881 |
April 05, 2024 | 4.881 |
April 04, 2024 | 4.881 |
April 03, 2024 | 4.754 |
April 02, 2024 | 4.886 |
April 01, 2024 | 4.963 |
March 31, 2024 | |
March 28, 2024 | 4.227 |
March 27, 2024 | 4.191 |
March 26, 2024 | 4.191 |
March 25, 2024 | 4.191 |
March 22, 2024 | 4.222 |
March 21, 2024 | 4.222 |
March 20, 2024 | 4.120 |
March 19, 2024 | 4.244 |
March 18, 2024 | 4.38 |
March 15, 2024 | 4.38 |
March 14, 2024 | 4.38 |
March 13, 2024 | 4.297 |
March 12, 2024 | 4.306 |
March 11, 2024 | 4.325 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.110
Minimum
Sep 27 2022
5.386
Maximum
Dec 28 2023
3.200
Average
3.152
Median
Aug 03 2021
Price to Book Value Benchmarks
Sandoz Group AG | -- |
Roche Holding AG | 5.996 |
ADC Therapeutics SA | -- |
AC Immune SA | 1.961 |
Price to Book Value Related Metrics
PE Ratio | 13.93 |
PS Ratio | 4.245 |
PEG Ratio | 0.111 |
Price to Free Cash Flow | 20.69 |
Price | 102.14 |
Earnings Yield | 7.18% |
Market Cap | 208.41B |
PEGY Ratio | 0.1079 |
Operating PE Ratio | 19.92 |
Normalized PE Ratio | 23.11 |